Valuation Gilead Sciences, Inc. Wiener Boerse

Stocks

End-of-day quote Wiener Boerse Other stock markets 2026-08-11			5-day change	1st Jan Change
116.36 ^EUR	+0.52%		+2.61%	+9.65%

08-11	Global drugmakers invest billions to boost US presence	RE
08-05	Gilead Sciences Delivers 'Plenty' to Like in Q2, RBC Says	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	91,081	107,677	100,942	115,118	152,281	168,349	-	-
Change	-	18.22%	-6.25%	14.04%	32.28%	10.55%	-	-
Enterprise Value (EV) ¹	118,530	126,522	118,665	131,838	169,585	185,094	177,473	171,183
Change	-	6.74%	-6.21%	11.1%	28.63%	9.15%	-4.12%	-3.54%
P/E	14.7x	23.6x	18x	243x	18.1x	-42.2x	17x	15.7x
PBR	4.32x	5.05x	4.48x	5.98x	6.73x	8.38x	6.99x	5.6x
PEG	-	-0.9x	0.8x	-2.7x	0x	0x	-0x	1.84x
Capitalization / Revenue	3.34x	3.95x	3.72x	4x	5.17x	5.49x	5.15x	4.9x
EV / Revenue	4.34x	4.64x	4.38x	4.59x	5.76x	6.03x	5.43x	4.99x
EV / EBITDA	8.12x	8.86x	9.01x	11.7x	10.6x	34x	10x	9.41x
EV / EBIT	9.45x	10.4x	11.3x	15.5x	12.9x	58.4x	11.2x	10.1x
EV / FCF	11x	15.2x	16x	12.8x	17.9x	-351x	13.6x	12.4x
FCF Yield	9.12%	6.59%	6.25%	7.82%	5.58%	-0.28%	7.38%	8.07%
Dividend per Share ²	2.84	2.92	3	3.08	3.16	3.296	3.409	3.102
Rate of return	3.91%	3.4%	3.7%	3.33%	2.57%	2.43%	2.51%	2.28%
EPS ²	4.93	3.64	4.5	0.38	6.78	-3.22	7.985	8.666
Distribution rate	57.6%	80.2%	66.7%	811%	46.6%	-102%	42.7%	35.8%
Net sales ¹	27,305	27,281	27,116	28,754	29,443	30,691	32,674	34,329
EBITDA ¹	14,598	14,283	13,177	11,287	15,953	5,437	17,720	18,199
EBIT ¹	12,548	12,180	10,484	8,520	13,193	3,170	15,831	16,891
Net income ¹	6,225	4,592	5,665	480	8,510	-4,165	10,209	10,860
Net Debt ¹	27,449	18,845	17,723	16,720	17,304	16,745	9,125	2,835
Reference price ²	72.61	85.85	81.01	92.37	122.74	135.77	135.77	135.77
Nbr of stocks (in thousands)	1,254,384	1,254,244	1,246,042	1,246,266	1,240,680	1,239,955	-	-
Announcement Date	2/1/22	2/2/23	2/6/24	2/11/25	2/10/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
ELI LILLY AND COMPANY	34.93x	12.78x	25.81x	0.56%	1,098B
JOHNSON & JOHNSON	29.12x	-	-	2.05%	631B
ABBVIE INC.	31.66x	7.38x	15.33x	2.77%	438B
ROCHE HOLDING AG	20.79x	4.93x	12.21x	2.68%	368B
NOVARTIS AG	22.24x	5.75x	14.34x	2.79%	298B
ASTRAZENECA PLC	20.77x	4.28x	12.16x	2.05%	251B
AMGEN INC.	26.18x	6.87x	12.22x	2.42%	226B
NOVO NORDISK A/S	13.88x	4.98x	10.54x	3.66%	209B
GILEAD SCIENCES, INC.	-41.32x	5.92x	33.42x	2.48%	165B
Average	17.58x	6.61x	17.00x	2.38%	409.37B
Weighted average by Cap.	25.00x	8.33x	18.79x	1.95%